Anupam Rasayan India Ltd has announced the acquisition of 260,065 equity shares in Tanfac Industries Ltd for approximately Rs 60.88 crore. The company also set September 30, 2026, as the date for its 23rd Annual General Meeting, with a dividend record date of September 18, 2026. Additionally, Ms. Hetvi Vyas has been appointed as the new Deputy CFO and Key Managerial Personnel.
Anupam Rasayan Announces Strategic Acquisition and AGM Updates
Aggregate Acquisition: Rs 60.88 crore | AGM Date: September 30, 2026
Reader Takeaway: Strategic investment in Tanfac expands business footprint while new leadership strengthens the internal financial oversight team.
What just happened
Anupam Rasayan India Ltd has officially announced a strategic acquisition of 260,065 equity shares of Tanfac Industries Limited. The transaction involves a total investment of Rs 60.88 crore, priced at Rs 2,341 per share. Simultaneously, the company confirmed that its 23rd Annual General Meeting (AGM) will take place on September 30, 2026, via video conferencing. The Board has also appointed Ms. Hetvi Vyas as Deputy CFO and Key Managerial Personnel.
Why this matters
The acquisition represents a significant capital allocation move, signaling the company's intent to strengthen its position in relevant industrial sectors through Tanfac Industries. For shareholders, the announcement of the dividend record date (September 18, 2026) provides clarity on the upcoming final dividend payout for the 2025-26 fiscal year, pending member approval at the AGM.
Governance Update
The addition of Ms. Hetvi Vyas to the leadership team as Deputy CFO indicates a move to bolster the company’s financial reporting and governance framework. Her role as Key Managerial Personnel places her among the top officials responsible for the company's fiscal strategy.
What to track next
Investors should monitor the upcoming AGM proceedings, particularly any management commentary regarding the expected synergies from the Tanfac stake acquisition. Further developments regarding the integration of this investment and the company’s broader financial health will be central to evaluating long-term value creation.
